PER percheron therapeutics limited

Ann: Percheron launches post-trial access program, page-6

  1. 8,356 Posts.
    lightbulb Created with Sketch. 2089
    Irrespective of what SHs have posted here about the corporate side of things the drug seems to be working and the patients and doctors want continued access to the drug. This is very reassuring and gives hope/ confidence that the Dec readout will be very good. That’s my bet anyway.

    No advice. DYOR.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $1.62K 180K

Buyers (Bids)

No. Vol. Price($)
4 364826 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 8026021 8
View Market Depth
Last trade - 10.37am 25/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.